scholarly article | Q13442814 |
P50 | author | Chao Xing | Q41503549 |
Wenting Du | Q61475916 | ||
Huocong Huang | Q64148600 | ||
Rolf Brekken | Q89067063 | ||
Yuqing Zhang | Q90687453 | ||
P2093 | author name string | Eugene J Koay | |
Steven Wright | |||
Kyla E Driscoll | |||
Adwait Amod Sathe | |||
Zhaoning Wang | |||
Abdel Nasser Hosein | |||
Noah Sorrelle | |||
Jason Toombs | |||
Mohamed Medhat Zaid | |||
Moriah Hagopian | |||
Valerie Gallegos | |||
P2860 | cites work | The basics of epithelial-mesenchymal transition | Q24652992 |
The pancreas cancer microenvironment | Q27026705 | ||
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma | Q27824778 | ||
TGFβ signalling in context | Q28275410 | ||
TGFbeta in Cancer | Q28288866 | ||
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance | Q28504893 | ||
STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
Macrophage activation and polarization | Q29616353 | ||
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
TGF-beta-induced epithelial to mesenchymal transition | Q29619820 | ||
Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma | Q33896442 | ||
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival | Q34269713 | ||
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression | Q35127700 | ||
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. | Q35740663 | ||
Whole genomes redefine the mutational landscape of pancreatic cancer | Q35911034 | ||
Pancreatic cancer-associated stroma production | Q36168805 | ||
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia | Q36772346 | ||
Basics of TGF-beta and pancreatic cancer | Q36953049 | ||
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. | Q37683769 | ||
Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. | Q38325637 | ||
Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis | Q38971921 | ||
LIF mediates proinvasive activation of stromal fibroblasts in cancer | Q38992217 | ||
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer | Q39076225 | ||
Novel TGF-β inhibitors ready for prime time in onco-immunology | Q39135708 | ||
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 | ||
Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. | Q39411956 | ||
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. | Q39540918 | ||
Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells | Q39741489 | ||
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity | Q40351340 | ||
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance | Q40351779 | ||
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway | Q40788629 | ||
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression | Q41892306 | ||
TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis | Q42775736 | ||
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival | Q44680447 | ||
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis | Q50001731 | ||
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Q50001757 | ||
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. | Q50173304 | ||
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling. | Q51709053 | ||
Contextual determinants of TGFβ action in development, immunity and cancer. | Q52593116 | ||
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance | Q57174100 | ||
IL-1-induced JAK/STAT signaling is antagonized by TGF-beta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma | Q58113127 | ||
Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression | Q58548008 | ||
Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1 | Q58785737 | ||
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer | Q60594558 | ||
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness | Q69880388 | ||
Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects | Q77653649 | ||
Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues | Q90226839 | ||
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis | Q91264732 | ||
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution | Q92118472 | ||
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer | Q92470740 | ||
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts | Q92732735 | ||
P4510 | describes a project that uses | edgeR | Q113334690 |
P433 | issue | 11 | |
P921 | main subject | pancreatic cancer | Q212961 |
P304 | page(s) | e10515 | |
P577 | publication date | 2019-10-14 | |
P1433 | published in | EMBO Molecular Medicine | Q15817279 |
P1476 | title | Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer | |
P478 | volume | 11 |
Q94562389 | Pancreatic cancer stroma: an update on therapeutic targeting strategies |
Q97867213 | TGFβ biology in cancer progression and immunotherapy |
Q104795035 | Targeting TGFβ signal transduction for cancer therapy |
Search more.